Sensei Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10.56	9.99	13.01	17.8	7.16	16.6
Short-Term Investments	14.48	31.34	52.75	89.32	140.46	-
Cash & Short-Term Investments	25.04	41.34	65.76	107.12	147.62	16.6
Cash Growth	-46.72%	-37.14%	-38.61%	-27.44%	789.50%	6511.95%
Prepaid Expenses	0.5	0.47	1.17	1.13	0.55	1.38
Other Current Assets	0.25	0.12	0.33	0.34	0.37	2.11
Total Current Assets	25.79	41.93	67.25	108.59	148.54	20.08
Property, Plant & Equipment	1.79	3.38	7.04	9.72	4.64	1.27
Other Long-Term Assets	0.02	0.05	0.09	0.06	0.04	0.09
Total Assets	27.59	45.36	74.37	118.38	153.23	21.43
Accounts Payable	0.31	0.24	0.57	4.47	2.46	3.88
Accrued Expenses	2.18	2.73	2.41	2.46	1.75	0.92
Current Portion of Leases	1.88	2.32	2.44	2.13	0.68	0.03
Other Current Liabilities	0.08	0.16	0.22	-	-	-
Total Current Liabilities	4.44	5.45	5.64	9.07	4.89	4.83
Long-Term Debt	-	-	-	-	-	0.57
Long-Term Leases	0.15	1.53	3.77	5.9	1.67	0.09
Other Long-Term Liabilities	-	-	0.07	-	0.15	0.05
Total Liabilities	4.58	6.98	9.48	14.97	6.71	5.54
Common Stock	-	0	0	0	0	-
Additional Paid-In Capital	301.43	300.45	297	302.2	296.05	55.97
Retained Earnings	-278.42	-262.05	-231.9	-197.79	-149.21	-112.41
Comprehensive Income & Other	-0	-0.01	-0.21	-1	-0.33	-
Total Common Equity	23.01	38.39	64.9	103.41	146.51	-56.44
Shareholders' Equity	23.01	38.39	64.9	103.41	146.51	15.89
Total Liabilities & Equity	27.59	45.36	74.37	118.38	153.23	21.43
Total Debt	2.02	3.85	6.21	8.03	2.35	0.69
Net Cash (Debt)	23.02	37.49	59.55	99.08	145.27	15.91
Net Cash Growth	-45.88%	-37.04%	-39.90%	-31.79%	813.00%	-
Net Cash Per Share	18.27	29.85	42.61	64.54	104.85	197.39
Filing Date Shares Outstanding	1.26	1.26	1.25	1.55	1.53	1.53
Total Common Shares Outstanding	1.26	1.26	1.25	1.54	1.53	0.09
Working Capital	21.35	36.48	61.61	99.52	143.65	15.25
Book Value Per Share	18.24	30.49	51.85	67.23	95.73	-601.92
Tangible Book Value	23.01	38.39	64.9	103.41	146.51	-56.44
Tangible Book Value Per Share	18.24	30.49	51.85	67.23	95.73	-601.92
Machinery	0.37	1.66	2.64	3.24	5.58	1.86
Leasehold Improvements	0.25	0.25	0.25	0.25	0.25	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q